Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
149 | EPC - European Pharmaceutical Contractor | journal | 3 | 7 | 0 | 20 | 0 | 0 | 0.00 | 2.86 | ||
148 | Industrial Pharmacy | trade journal | 0.108 Q4 | 5 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | |
147 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.102 Q4 | 3 | 0 | 14 | 0 | 0 | 14 | 0.00 | 0.00 | |
146 | Drug Discovery Today: Disease Models | journal | 0.665 Q2 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | |
145 | Antiviral Chemistry and Chemotherapy | journal | 0.369 Q3 | 59 | 2 | 29 | 41 | 62 | 28 | 0.87 | 20.50 | |
144 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.166 Q3 | 7 | 13 | 35 | 214 | 10 | 34 | 0.24 | 16.46 | |
143 | GMP Review | trade journal | 0.101 Q4 | 2 | 4 | 39 | 28 | 0 | 24 | 0.00 | 7.00 | |
142 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 16 | 44 | 2659 | 318 | 44 | 7.14 | 166.19 | |
141 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | |
140 | Drug Discovery Today: Technologies | journal | 1.241 Q1 | 62 | 0 | 53 | 0 | 295 | 48 | 3.50 | 0.00 | |
139 | Pharmaceutical patent analyst | journal | 0.351 Q2 | 20 | 26 | 62 | 1235 | 71 | 50 | 1.18 | 47.50 | |
138 | Mathematical Medicine and Biology | journal | 0.276 Q3 | 49 | 15 | 63 | 536 | 67 | 63 | 1.10 | 35.73 | |
137 | International Journal of Computational Biology and Drug Design | journal | 0.120 Q4 | 16 | 14 | 80 | 527 | 27 | 79 | 0.50 | 37.64 | |
136 | Expert Opinion on Orphan Drugs | journal | 0.199 Q3 | 27 | 3 | 85 | 174 | 66 | 82 | 0.86 | 58.00 | |
135 | Biopharmaceutics and Drug Disposition | journal | 0.396 Q2 | 65 | 36 | 91 | 1728 | 188 | 89 | 1.91 | 48.00 | |
134 | Food Additives and Contaminants | journal | 0.364 Q3 | 121 | 124 | 92 | 5425 | 186 | 92 | 1.81 | 43.75 | |
133 | Toxicon: X | journal | 0.870 Q1 | 16 | 20 | 97 | 1404 | 356 | 96 | 4.11 | 70.20 | |
132 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q3 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | |
131 | Journal of Liposome Research | journal | 0.747 Q1 | 64 | 46 | 102 | 3388 | 565 | 102 | 4.11 | 73.65 | |
130 | Antiviral Therapy | journal | 0.447 Q3 | 93 | 24 | 105 | 935 | 154 | 102 | 1.45 | 38.96 | |
129 | Food Additives and Contaminants: Part B Surveillance | journal | 0.557 Q3 | 41 | 39 | 107 | 1681 | 336 | 107 | 3.07 | 43.10 | |
128 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | |
127 | Journal of Occupational Medicine and Toxicology | journal | 0.868 Q1 | 47 | 31 | 109 | 1321 | 366 | 108 | 3.10 | 42.61 | |
126 | Expert Opinion on Emerging Drugs | journal | 0.881 Q2 | 54 | 29 | 110 | 2695 | 321 | 102 | 2.62 | 92.93 | |
125 | Mutagenesis | journal | 0.859 Q1 | 102 | 33 | 110 | 1033 | 314 | 107 | 2.85 | 31.30 | |
124 | Drugs in R and D | journal | 0.708 Q2 | 54 | 40 | 111 | 1687 | 296 | 107 | 2.41 | 42.18 | |
123 | Inhalation Toxicology | journal | 0.440 Q3 | 97 | 32 | 111 | 1810 | 226 | 107 | 2.02 | 56.56 | |
122 | Journal of Biologically Active Products from Nature | journal | 0.243 Q3 | 18 | 39 | 112 | 1772 | 149 | 111 | 1.14 | 45.44 | |
121 | Environmental Pollutants and Bioavailability | journal | 0.659 Q2 | 39 | 53 | 114 | 3294 | 424 | 113 | 3.90 | 62.15 | |
120 | EPMA Journal | journal | 1.370 Q1 | 52 | 41 | 114 | 3583 | 830 | 111 | 7.32 | 87.39 | |
119 | ATLA Alternatives to Laboratory Animals | journal | 0.397 Q3 | 65 | 34 | 119 | 1450 | 187 | 92 | 1.35 | 42.65 | |
118 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.471 Q2 | 46 | 40 | 122 | 2294 | 361 | 122 | 2.52 | 57.35 | |
117 | npj Systems Biology and Applications | journal | 1.248 Q1 | 35 | 61 | 127 | 3945 | 467 | 126 | 3.68 | 64.67 | |
116 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.453 Q3 | 41 | 20 | 131 | 1498 | 307 | 131 | 2.19 | 74.90 | |
115 | Critical Reviews in Toxicology | journal | 1.180 Q1 | 129 | 31 | 138 | 3968 | 721 | 127 | 4.39 | 128.00 | |
114 | Current Opinion in Systems Biology | journal | 1.676 Q1 | 34 | 21 | 140 | 1378 | 455 | 131 | 3.24 | 65.62 | |
113 | Journal of Microencapsulation | journal | 0.511 Q2 | 88 | 43 | 145 | 2620 | 535 | 145 | 3.26 | 60.93 | |
112 | Personalized Medicine | journal | 0.412 Q3 | 36 | 43 | 146 | 1840 | 255 | 138 | 1.62 | 42.79 | |
111 | SAR and QSAR in Environmental Research | journal | 0.359 Q3 | 54 | 49 | 147 | 2680 | 414 | 147 | 2.58 | 54.69 | |
110 | Journal of Cannabis Research | journal | 0.692 Q2 | 17 | 39 | 148 | 1666 | 627 | 144 | 4.35 | 42.72 | |
109 | DARU, Journal of Pharmaceutical Sciences | journal | 0.625 Q2 | 58 | 43 | 149 | 2213 | 587 | 146 | 2.80 | 51.47 | |
108 | Cutaneous and Ocular Toxicology | journal | 0.457 Q3 | 37 | 42 | 153 | 1584 | 277 | 149 | 1.74 | 37.71 | |
107 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.326 Q3 | 54 | 51 | 154 | 1785 | 212 | 134 | 0.86 | 35.00 | |
106 | Journal of Peptide Science | journal | 0.352 Q3 | 73 | 78 | 164 | 3861 | 288 | 163 | 1.74 | 49.50 | |
105 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 0 | 164 | 0 | 0 | 162 | 0.00 | 0.00 | |
104 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | |
103 | BioDrugs | journal | 1.796 Q1 | 79 | 62 | 166 | 5182 | 1068 | 161 | 5.59 | 83.58 | |
102 | Regulatory Rapporteur | trade journal | 0.101 Q4 | 7 | 69 | 167 | 715 | 3 | 96 | 0.03 | 10.36 | |
101 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | |
100 | Molecular Diagnosis and Therapy | journal | 1.214 Q1 | 68 | 55 | 174 | 4152 | 719 | 171 | 4.28 | 75.49 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®